Literature DB >> 31599413

Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.

W-G Liu1, Q Xu.   

Abstract

OBJECTIVE: To elucidate the regulatory effect of circular RNA HIPK3 (circHIPK3) on the progression of gastric cancer (GC) by regulating the Wnt/β-catenin pathway. We aim to reveal whether the abnormal expression of circHIPK3 could predict the poor prognosis of GC. PATIENTS AND METHODS: CircHIPK3 level in GC tissues and paracancerous tissues was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Its level in GC cell lines (BGC, MGC, SGC and MKN) and gastric mucosal cell line (GES) was examined as well. The correlation between the circHIPK3 level and overall survival of GC was analyzed by the Kaplan-Meier method. Regulatory effects of circHIPK3 on the proliferative ability of GC cells were evaluated by Cell Counting Kit-8 (CCK-8) and colony formation assay, respectively. Migratory changes influenced by circHIPK3 were explored through wound healing assay. The expression levels of relative genes in the Wnt/β-catenin pathway were detected in GC cells with circHIPK3 knockdown. Finally, the Wnt/β-catenin pathway inhibitor PNU-74654 was applied for detecting its influence on cellular behaviors of GC cells.
RESULTS: CircHIPK3 level was higher in GC tissues relative to paracancerous tissues. Identically, its level was higher in GC cells compared with that of GES cells. The expression level of circHIPK3 was negatively correlated to the overall survival of GC patients. Silence of circHIPK3 weakened proliferative and migratory abilities of GC cells. In addition, circHIPK3 knockdown markedly downregulated levels of WNT1, TCF4 and β-catenin. Application of PNU-74654 weakened the abilities of GC cells to proliferate and migrate.
CONCLUSIONS: CircHIPK3 promotes GC cells to proliferate and migrate by regulating the Wnt/β-catenin pathway. Upregulation of circHIPK3 indicates poor prognosis of GC patients.

Entities:  

Year:  2019        PMID: 31599413     DOI: 10.26355/eurrev_201909_19004

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  16 in total

Review 1.  CircHIPK3: a promising cancer-related circular RNA.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 2.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

Review 3.  Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.

Authors:  Xueping Tao; Yongfu Shao; Jianing Yan; Liyang Yang; Qihua Ye; Qingling Wang; Rongdan Lu; Junming Guo
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

4.  Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion.

Authors:  Li Li; Qiaohua Zhang; Ke Lian
Journal:  Cancer Cell Int       Date:  2020-06-16       Impact factor: 5.722

5.  CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.

Authors:  Yunfei Liu; Li Xia; Luo Dong; Jiale Wang; Qiangsheng Xiao; Xiao Yu; Hongwei Zhu
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

Review 6.  Current Understanding of Circular RNAs in Gastric Cancer.

Authors:  Xiaohuan Tang; Jiaming Zhu; Yuanda Liu; Chao Chen; Tianzhou Liu; Jingjing Liu
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

7.  Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.

Authors:  D C Liu; L L Song; X Z Li; Q Liang; Z G Zhang; C H Han
Journal:  Clin Transl Oncol       Date:  2021-06-17       Impact factor: 3.405

Review 8.  The Biogenesis, Functions, and Roles of circRNAs in Bladder Cancer.

Authors:  Changjiu Li; Xian Fu; Huadong He; Chao Chen; Yuyong Wang; Lugeng He
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

Review 9.  Noncoding RNAs in gastric cancer: implications for drug resistance.

Authors:  Ling Wei; Jujie Sun; Nasha Zhang; Yan Zheng; Xingwu Wang; Liyan Lv; Jiandong Liu; Yeyang Xu; Yue Shen; Ming Yang
Journal:  Mol Cancer       Date:  2020-03-19       Impact factor: 27.401

Review 10.  CircRNAs in anticancer drug resistance: recent advances and future potential.

Authors:  Tianwei Xu; Mengwei Wang; Lihua Jiang; Li Ma; Li Wan; Qinnan Chen; Chenchen Wei; Zhaoxia Wang
Journal:  Mol Cancer       Date:  2020-08-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.